494 related articles for article (PubMed ID: 9419419)
21. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
Lane S; Farlie P; Watson R
Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
[TBL] [Abstract][Full Text] [Related]
22. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
23. B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells.
Raschellà G; Negroni A; Pucci S; Amendola R; Valeri S; Calabretta B
Exp Cell Res; 1996 Feb; 222(2):395-9. PubMed ID: 8598228
[TBL] [Abstract][Full Text] [Related]
24. c-Myb function in fibroblasts.
Bein K; Husain M; Ware JA; Mucenski ML; Rosenberg RD; Simons M
J Cell Physiol; 1997 Dec; 173(3):319-26. PubMed ID: 9369944
[TBL] [Abstract][Full Text] [Related]
25. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
26. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
27. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
29. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
30. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
31. Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins.
Rushton JJ; Davis LM; Lei W; Mo X; Leutz A; Ness SA
Oncogene; 2003 Jan; 22(2):308-13. PubMed ID: 12527900
[TBL] [Abstract][Full Text] [Related]
32. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
33. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
34. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes.
Hass R; Gunji H; Datta R; Kharbanda S; Hartmann A; Weichselbaum R; Kufe D
Cancer Res; 1992 Mar; 52(6):1445-50. PubMed ID: 1531783
[TBL] [Abstract][Full Text] [Related]
35. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
Akashi M; Osawa Y; Koeffler HP; Hachiya M
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
[TBL] [Abstract][Full Text] [Related]
36. The A-Myb transcription factor is a marker of centroblasts in vivo.
Golay J; Broccoli V; Lamorte G; Bifulco C; Parravicini C; Pizzey A; Thomas NS; Delia D; Ferrauti P; Vitolo D; Introna M
J Immunol; 1998 Mar; 160(6):2786-93. PubMed ID: 9510180
[TBL] [Abstract][Full Text] [Related]
37. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
[TBL] [Abstract][Full Text] [Related]
39. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
Rosato RR; Almenara JA; Grant S
Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
[TBL] [Abstract][Full Text] [Related]
40. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]